Comparative miRNA Expression Profiles in Individuals with Latent and Active Tuberculosis

The mechanism of latent tuberculosis (TB) infection remains elusive. Several host factors that are involved in this complex process were previously identified. Micro RNAs (miRNAs) are endogenous ∼22 nt RNAs that play important regulatory roles in a wide range of biological processes. Several studies demonstrated the clinical usefulness of miRNAs as diagnostic or prognostic biomarkers in various malignancies and in a few nonmalignant diseases. To study the role of miRNAs in the transition from latent to active TB and to discover candidate biomarkers of this transition, we used human miRNA microarrays to probe the transcriptome of peripheral blood mononuclear cells (PBMCs) in patients with active TB, latent TB infection (LTBI), and healthy controls. Using the software package BRB Array Tools for data analyses, 17 miRNAs were differentially expressed between the three groups (P<0.01). Hierarchical clustering of the 17 miRNAs expression profiles showed that individuals with active TB clustered independently of individuals with LTBI or from healthy controls. Using the predicted target genes and previously published genome-wide transcriptional profiles, we constructed the regulatory networks of miRNAs that were differentially expressed between active TB and LTBI. The regulatory network revealed that several miRNAs, with previously established functions in hematopoietic cell differentiation and their target genes may be involved in the transition from latent to active TB. These results increase the understanding of the molecular basis of LTBI and confirm that some miRNAs may control gene expression of pathways that are important for the pathogenesis of this infectious disease.

[1]  Stefan H E Kaufmann,et al.  Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis , 2005, Nature Medicine.

[2]  Bin Wang,et al.  Systematic Evaluation of Three microRNA Profiling Platforms: Microarray, Beads Array, and Quantitative Real-Time PCR Array , 2011, PloS one.

[3]  P. Selwyn,et al.  Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. , 1992, The New England journal of medicine.

[4]  Deepak Srivastava,et al.  MicroRNAs as regulators of differentiation and cell fate decisions. , 2010, Cell stem cell.

[5]  H. Lodish,et al.  Micromanagement of the immune system by microRNAs , 2008, Nature Reviews Immunology.

[6]  D Repsilber,et al.  Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.

[7]  O. Kirak,et al.  Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 , 2008, Nature.

[8]  K. Horimoto,et al.  Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma , 2009, Hepatology.

[9]  E. Rubin,et al.  Letting sleeping dos lie: does dormancy play a role in tuberculosis? , 2010, Annual review of microbiology.

[10]  G. Pantaleo,et al.  Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease , 2011, Nature Medicine.

[11]  J. Flynn,et al.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.

[12]  S. Kauppinen,et al.  Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.

[13]  Dirk Repsilber,et al.  Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis , 2007, Journal of Molecular Medicine.

[14]  Yoshinori Tanaka,et al.  Survival of Virulent Mycobacterium tuberculosis Involves Preventing Apoptosis Induced by Bcl‐2 Upregulation and Release Resulting from Necrosis in J774 Macrophages , 2005, Microbiology and immunology.

[15]  Kyoko Ochiai,et al.  Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation. , 2007, Journal of biochemistry.

[16]  C. Croce,et al.  MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Ryan M. O’Connell,et al.  MicroRNAs: new regulators of immune cell development and function , 2008, Nature Immunology.

[18]  M. Behr,et al.  Transmission of tuberculosis in a high incidence urban community in South Africa. , 2004, International journal of epidemiology.

[19]  A. Fatica,et al.  The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation , 2007, Proceedings of the National Academy of Sciences.

[20]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[21]  Xiaomin Zhao,et al.  Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis , 2011, Mucosal Immunology.

[22]  Byoung-Tak Zhang,et al.  BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm045 Data and text mining Discovery of microRNA–mRNA modules via population-based probabilistic learning , 2007 .

[23]  Sarah G. Bailey,et al.  Regulating the genome surveillance system: miRNAs and the p53 super family , 2010, Apoptosis.

[24]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[25]  B. Cullen,et al.  Viruses, microRNAs, and host interactions. , 2010, Annual review of microbiology.

[26]  Damien Chaussabel,et al.  Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis , 2009, Genome Biology.

[27]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[28]  Yitzhak Pilpel,et al.  Global and Local Architecture of the Mammalian microRNA–Transcription Factor Regulatory Network , 2007, PLoS Comput. Biol..

[29]  M Suzuki,et al.  Explorer Induction of microRNAs , mir-155 , mir-222 , mir-424 and mir-503 , promotes monocytic differentiation through combinatorial regulation , 2010 .

[30]  Remco Dijkman,et al.  Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  B. Gastel Book Review Sentinel for Health: A History of the Centers for Disease Control By Elizabeth W. Etheridge. 414 pp., illustrated. Berkeley, Calif., University of California Press, 1992. $42.50. 0-520-07107-7 , 1993 .

[32]  D. Dykxhoorn MicroRNAs and metastasis: little RNAs go a long way. , 2010, Cancer research.

[33]  Yingdong Zhao,et al.  BRB-ArrayTools Data Archive for Human Cancer Gene Expression: A Unique and Efficient Data Sharing Resource , 2008, Cancer informatics.

[34]  Tapas K Sengupta,et al.  Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. , 2007, Blood.

[35]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[36]  JoAnne L. Flynn,et al.  Understanding Latent Tuberculosis: A Moving Target , 2010, The Journal of Immunology.

[37]  L. Bally-Cuif,et al.  MicroRNAs in brain development and physiology , 2009, Current Opinion in Neurobiology.

[38]  J. Casanova,et al.  Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.

[39]  Anton J. Enright,et al.  The miR-144/451 locus is required for erythroid homeostasis , 2010, The Journal of experimental medicine.